[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condbio:hepatocellular-carcinoma:alpha-fetoprotein":3},{"condition":4,"biomarker":5,"total":6,"trials":7},"Hepatocellular Carcinoma","Alpha-Fetoprotein",4,[8,16,23,30],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07059494","Atezolizumab and Bevacizumab in Combination With Y^90 Radioembolization in HCC for Liver Transplant",[12],"Phase 4","RECRUITING","2026-08-26T02:17:32.059863Z","2026-05-05T02:43:27.947322Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT07075120","Ipilimumab and Nivolumab With SBRT in Locally Advanced Hepatocellular Cancer",[20],"Phase 1","2026-08-26T02:19:23.493898Z","2026-05-05T02:43:27.509471Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":28,"content_modified":29},"NCT04634357","ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma",[27],"Phase 1\u002FPhase 2","2026-08-26T02:17:21.315591Z","2026-07-19T19:36:05.119597Z",{"nct_id":31,"title":32,"phases":33,"status":34,"updated_at":35,"content_modified":36},"NCT02379377","18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant",[20],"ACTIVE_NOT_RECRUITING","2026-08-03T03:14:40.336483Z","2026-05-05T02:43:28.416923Z"]